Automate Your Wheel Strategy on BGM
With Tiblio's Option Bot, you can configure your own wheel strategy including BGM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BGM
- Rev/Share 3.4731
- Book/Share 6.1016
- PB 1.5512
- Debt/Equity 0.0
- CurrentRatio 3.3921
- ROIC -0.009
- MktCap 1780590608.0
- FreeCF/Share -0.4687
- PFCF -525.677
- PE -45.9534
- Debt/Assets 0.0
- DivYield 0
- ROE -0.0337
- Rating
- Score
- Recommendation
- P/E Score
- DCF Score
- P/B Score
- D/E Score
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
BGM Completes Acquisition of YX to Advance AI-Powered Intelligent Platform
BGM
Published: April 28, 2025 by: PRNewsWire
Sentiment: Neutral
Published: April 28, 2025 by: PRNewsWire
Sentiment: Neutral
CHENGDU, China , April 28, 2025 /PRNewswire/ -- BGM Group Ltd. (NASDAQ: BGM) (the "Company" or BGM) today announced the completion of its acquisition of YX Management Company Ltd.
Read More
About BGM Group Ltd. (BGM)
- IPO Date 2003-01-24
- Website https://www.bgm.ltd
- Industry Drug Manufacturers - Specialty & Generic
- CEO Chen Xin
- Employees 298
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was formerly known as Qilian International Holding Group Limited and changed its name to BGM Group Ltd in October 2024. BGM Group Ltd was incorporated in 2019 and is based in Chengdu, the People's Republic of China.